Sector revisions CONMED Corporation

Stocks

Market Closed - NYSE 16:00:03 2026-09-04 EDT			5-day change	1st Jan Change
49.32 ^USD	-0.20%		-1.32%	+21.48%

07-30	CONMED Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Raised	MT
07-30	CONMED Corporation, Q2 2026 Earnings Call, Jul 29, 2026

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	CONMED CORPORATION							6
	ABBOTT LABORATORIES							25
	MEDTRONIC PLC							25
	CENCORA, INC.							13
	HOYA CORPORATION							15
	BECTON, DICKINSON AND COMPANY							12
	DEXCOM, INC.							25
	MEDLINE INC.							25
	WEST PHARMACEUTICAL SERVICES, INC.							15
	TERUMO CORPORATION							13
	STERIS PLC							8
	SARTORIUS STEDIM BIOTECH							14
	ZIMMER BIOMET HOLDINGS, INC.							21
	SOLVENTUM CORPORATION							13
	FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED							11
	BAXTER INTERNATIONAL INC.							11
	ALIGN TECHNOLOGY, INC.							15
	GLOBUS MEDICAL, INC.							13
	INSULET CORPORATION							22
	BIO-RAD LABORATORIES, INC.							5
	Average							15
	Weighted average by Cap.							19